Learn more

FEDERAL NOE G UCHREZHDENIE NAU

Overview
  • Total Patents
    243
About

FEDERAL NOE G UCHREZHDENIE NAU has a total of 243 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Russian Federation. Its main competitors in its focus markets environmental technology, measurement and medical technology are KLYUSHIN BORIS A, BRUSS N PROIZV OBEDINENIYA AGR and GL GEOFIZ OBSERVAT.

Patent filings in countries

World map showing FEDERAL NOE G UCHREZHDENIE NAUs patent filings in countries
# Country Total Patents
#1 Russian Federation 243

Patent filings per year

Chart showing FEDERAL NOE G UCHREZHDENIE NAUs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Shevtsov Vladimir Ivanovich 41
#2 Aleshkin Vladimir Andrianovich 24
#3 Afanas Ev Stanislav Stepanovich 11
#4 Rubal Skij Oleg Vasil Evich 11
#5 Khudjaev Aleksandr Timofeevich 10
#6 Davydkin Valerij Jur Evich 10
#7 Levchenko Tat Jana Aleksandrov 10
#8 Davydkin Igor Jur Evich 10
#9 Makushin Vadim Dmitrievich 9
#10 Afanas Ev Stanislav Stepanovic 9

Latest patents

Publication Filing date Title
RU2400753C1 Method of predicting course of chronic lympholuekemia
RU2398873C1 Method for making medical preparations
RU2390775C1 Differential diagnostic technique of inflammatory parodentium diseases parodonta, based on condition of local factors of nonspecific oral protection
RU2392017C1 Method of treatment of flourosis with concomitant osteoarthrosis
RU2400536C1 STRAIN OF BIRD FLU VIRUS OF A/common gull/Chany/2006 H5N1 SUBTYPE FOR PREPARATION OF ANTIGEN-CONTAINING DIAGNOSTIC OR VACCINE MEDICATION
RU2393229C1 Method for estimating adhesion staphylococcus spp to haemoproteins
RU2385946C1 Diagnostic technique for human or simian chlamidia infection and kit for implementation thereof
RU2385945C1 Method for prediction of human or simian manifested or obliterated chlamidia infection and kit for implementation thereof
RU2395577C1 STRAIN OF HYBRID ANIMAL CELLS Mus musculus L - PRODUCER OF MONOCLONAL ANTIBODIES FOR EXPOSING VP40 PROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN) (VERSIONS), MONOCLONAL ANTIBODY PRODUCED BY SAID STRAIN (VERSIONS) AND SET FOR "SANDWICH" FORMAT IMMUNOENZYMOMETRIC TEST SYSTEM FOR EXPOSING VP40 PROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN)
RU2395576C1 STRAIN OF HYBRID ANIMAL CELLS Mus museums L - PRODUCER OF MONOCLONAL ANTIBODIES FOR EXPOSING NUCLEOPROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN) (VERSIONS), MONOCLONAL ANTIBODY PRODUCED BY SAID STRAIN (VERSIONS) AND SET FOR "SANDWICH" FORMAT IMMUNOENZYMOMETRIC TEST SYSTEM FOR EXPOSING NUCLEOPROTEIN OF EBOLA VIRUS, ZAIRE SUBTYPE (Mainga STRAIN)
RU2393219C1 Strain of hybrid animal cells mus musculus l5f10-producer of monoclonal antibodies used for detecting pp65 protein of human cytomegalovirus
RU2393220C1 Strain of hybrid animal cells mus musculus l3f9 - producer of monoclonal antibodies suitable for use in "sandwitch" immunoenzymometric system format for detecting vp35 protein of marburg virus and 3f9 monoclonal antibodies produced by said strain of hybrid cells
RU2395575C1 STRAIN OF HYBRID ANIMAL CELLS Mus musculus L - PRODUCER OF MONOCLONAL ANTIBODIES FOR EXPOSING VP40 PROTEIN OF MARBURG VIRUS, (Popp STRAIN) (VERSIONS), MONOCLONAL ANTIBODY PRODUCED BY SAID STRAIN (VERSIONS) AND SET FOR "SANDWICH" FORMAT IMMUNOENZYMOMETRIC SYSTEM FOR EXPOSING VP40 MATRIX PROTEIN OF MARBURG VIRUS (Popp STRAIN)
RU2386133C1 Method for prediction of sterility in women working in petrochemical production
RU2392318C1 Method of stable cell cultures manufacture
RU2376606C1 Method and set for immune-enzyme detection of functional activity of component c4 of human complement
RU2393482C1 Method for preparing chlamidia antigen
RU2376605C1 Method and set for immune-enzyme detection of functuinal activity of factor d of human complement
RU2374650C1 Method and kit for immune-enzyme assay of functional activity of human complement factor b
RU2380707C1 Method and set for immunoenzyme assay of functional activity of component c3 of human complement by alternative pathway of activation